Meloxicam | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Meloxicam
HEALTH CANADA PATENTS

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Meloxicam

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 22 USDMF, 15 CEP/COS, 7 JDMF, 15 EU WC, 26 KDMF, 20 NDC API, 34 Listed Suppliers, $ API Reference Price

56 API Suppliers
22 USDMF
15 CEP/COS
7 JDMF
15 EU WC
26 KDMF
20 NDC API
34 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

47 Drugs in Development

47 Drugs in Development

INTERMEDIATES

13 Intermediates Suppliers

13 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

320 FDF Dossiers, 62 FDA Orange Book, 69 Europe, 34 Canada, 32 Australia, 44 South Africa, 79 Listed Dossiers

320 FDF Dossiers
62 FDA Orange Book
69 Europe
34 Canada
32 Australia
44 South Africa
79 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 15MG, TABLET;ORAL - 7.5MG, SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 7.5MG/5ML

TABLET;ORAL - 15MG
TABLET;ORAL - 7.5MG
SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SUSPENSION;ORAL - 7.5MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 3 Rochem International Inc, 8 SPI Pharma, 11 DKSH, 2 Jai Radhe Sales, 6 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 7 Actylis, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 7 DFE Pharma, 7 Gangwal Chemicals, 2 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qualicaps, 27 Roquette, 1 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 43 Disintegrants & Superdisintegrants, 41 Direct Compression, 26 Granulation, 25 Thickeners and Stabilizers, 21 Lubricants & Glidants, 19 Co-Processed Excipients, 17 Coating Systems & Additives, 16 Taste Masking, 14 Chewable & Orodispersible Aids, 13 Controlled & Modified Release, 12 Film Formers & Plasticizers, 10 Solubilizers, 9 Parenteral, 8 Empty Capsules, 7 Topical, 5 Rheology Modifiers, 4 Emulsifying Agents, 3 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

80 Fillers, Diluents & Binders
43 Disintegrants & Superdisintegrants
41 Direct Compression
26 Granulation
25 Thickeners and Stabilizers
21 Lubricants & Glidants
19 Co-Processed Excipients
17 Coating Systems & Additives
16 Taste Masking
14 Chewable & Orodispersible Aids
13 Controlled & Modified Release
12 Film Formers & Plasticizers
10 Solubilizers
9 Parenteral
8 Empty Capsules
7 Topical
5 Rheology Modifiers
4 Emulsifying Agents
3 API Stability Enhancers
2 Coloring Agents
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 46 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
46 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 57 Finished Drug Prices, 1 Annual Reports

3 US Medicaid Prescriptions
57 Finished Drug Prices
1 Annual Reports

MARKET PLACE

33 APIs, 2 FDF Dossiers, 1 Intermediates

33 APIs
2 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

81 US Patents, 8 US Exclusivities, 2 Health Canada Patents

81 US Patents
8 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 6 USP, 6 Others

5 EDQM
6 USP
6 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 96 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 1Boehringer Ingelheim (Canada) Ltd.

02 1Boehringer lngelheim Animal Health Canada Inc.

filter Patent Reset all filters

2 All

01 12326048

02 12414063

filter Product Reset all filters

2 All

01 2Meloxicam

filter Dosage Reset all filters

2 All

01 1Oral supension

02 1Solution for injection

filter Exp Date Reset all filters

2 All

01 12019-03-23

02 12021-06-19

Product Main Page

01

Boehringer lngelheim Animal Health Canada ...

Meloxicam

CPhI India 2024

Not Confirmed

Boehringer lngelheim Animal Health ...

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-06-19

Date Granted : 2008-06-17

Brand Name : METACAM

Patent Number : 2414063

Filing Date : 2001-06-19

Strength per Unit : 20 mg / mL

Dosage Form : Solution for injection

Human Or VET : Veterinary

Route of Administration : Intravenous, Subcutaneous

Patent Expiration Date : 2021-06-19

Date Granted : 2008-06-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Boehringer Ingelheim (Canada) Ltd.

Meloxicam

CPhI India 2024

Not Confirmed

Boehringer Ingelheim (Canada) Ltd.

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-03-23

Date Granted : 2008-08-12

Brand Name : METACAM

Patent Number : 2326048

Filing Date : 1999-03-23

Strength per Unit : 0.5 mg/mL

Dosage Form : Oral supension

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2019-03-23

Date Granted : 2008-08-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?